Vifor Pharma GlobalMedia releases
_In our media releases, you will find all news around Vifor Pharma at a glance. For media releases on the Galenica Group, please visit the global website.
Debiopharm and Vifor Pharma sign an exclusive agreement
Tuesday, 15 May 2012
A single 1,000 mg dose of Ferinject® rapidly improves fatigue symptoms in iron deficient, non-anaemic women
Tuesday, 17 April 2012
FDA assigns PDUFA Date for Injectafer® NDA
Thursday, 15 December 2011
Galenica strengthens its market position in Spain. It acquires all shares of Vifor Uriach Pharma as well as Grupo Uriach’s Primary Care Business.
Tuesday, 15 November 2011
New Injectafer® (US brand name of Ferinject®) data presented at the American Society of Nephrology’s Kidney Week 2011
Monday, 14 November 2011
New Injectafer® (US brand name of Ferinject®) data to be presented at the American Society of Nephrology’s Kidney Week 2011
Friday, 11 November 2011
Injectafer® NDA submitted to the US Food and Drug Administration
Thursday, 13 October 2011
Preoperative Anaemia Increases the Risk of Death and Major Morbidity in Surgical Patients
Friday, 7 October 2011
Vifor Fresenius Medical Care Renal Pharma Ltd. receives approval from European and Swiss antitrust authorities
Thursday, 6 October 2011
Vifor Pharma and Hikma Pharmaceuticals to collaborate in Middle East and North Africa
Wednesday, 17 August 2011
Contact
Vifor Pharma Ltd.
Global Communications
Flughofstrasse 61
P.O. Box
CH-8152 Glattbrugg
- Phone:
- +41 58 851 80 00
- Fax:
- +41 58 851 80 01
Galenica Ltd.
Media Relations
Untermattweg 8
CH-3027 Bern
- Phone:
- +41 58 852 85 17
- Fax:
- +41 58 852 85 58
Links